Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001127481 | SCV001286796 | uncertain significance | Ehlers-Danlos syndrome, arthrochalasia type | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127482 | SCV001286797 | uncertain significance | Osteogenesis imperfecta | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127483 | SCV001286798 | uncertain significance | Infantile cortical hyperostosis | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Labcorp Genetics |
RCV001219328 | SCV001391262 | likely benign | Osteogenesis imperfecta type I | 2024-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003380850 | SCV004088682 | uncertain significance | Cardiovascular phenotype | 2023-07-25 | criteria provided, single submitter | clinical testing | The p.A1083T variant (also known as c.3247G>A), located in coding exon 44 of the COL1A1 gene, results from a G to A substitution at nucleotide position 3247. The alanine at codon 1083 is replaced by threonine, an amino acid with similar properties. This alteration has been reported as compound heterozygous with an additional alteration in COL1A1 in an individual with osteogenesis imperfecta (OI) and was inherited from the unaffected mother (Ju M et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2016 Apr;33:140-4). Additionally, this alteration has been reported in an individual with primary congenital glaucoma; however, additional alterations in other related genes were identified (Mauri L et al. Orphanet J Rare Dis, 2016 Aug;11:108). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003480969 | SCV004224402 | uncertain significance | not provided | 2023-03-31 | criteria provided, single submitter | clinical testing | BP5, PP2 |